Pinned
Congratulations to #UMichPath researchers, Drs. Jolanta Grembecka and Tomasz Cierpicki on their recent @US_FDA approval of the first once-daily oral therapy for relapsed/refractory NPM1-mutant acute myeloid leukemia.
“This transformative discovery, grounded in research




























